Leor Matalon
Psychiatry · Vista, CANPI 1114952876
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 277 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 277 payments — averaging $41.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$1K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$864
- Teva Pharmaceuticals USA, Inc.$701
- plus $3K from 14 others
What the payments were for
- Food & beverage$11,37298%
- Education$2152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 59 | $2,265 |
| AbbVie(2 entities) | 54 | $2,027 |
| Sunovion Pharmaceuticals Inc. | 28 | $1,269 |
| Alkermes, Inc. | 19 | $1,176 |
| Otsuka America Pharmaceutical, Inc. | 13 | $864 |
| Teva Pharmaceuticals USA, Inc. | 14 | $701 |
| Supernus Pharmaceuticals, Inc. | 22 | $586 |
| Neurocrine Biosciences, Inc. | 5 | $491 |
| Tris Pharma Inc | 24 | $432 |
| Axsome Therapeutics, Inc. | 6 | $411 |
| Ironshore Pharmaceuticals Inc. | 5 | $319 |
| Johnson & Johnson | 5 | $270 |
| E.r. Squibb & Sons, L.L.C. | 2 | $246 |
| Idorsia Pharmaceuticals US Inc | 6 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $132 |
| Corium, LLC | 2 | $70 |
| Neos Therapeutics, LP | 2 | $43 |
| Lundbeck LLC | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$2,248
- CAPLYTA$1,483
- VRAYLAR$1,374
- ARISTADA$1,342
- REXULTI$616
- LATUDA$608
- INGREZZA$489
- ARISTADA INITIO$336
- COBENFY$246
- AUSTEDO$246
- QELBREE$230
- Auvelity$219
- SPRAVATO$125
- Jornay PM 20mg capsules (Bottle of 100)$125
- ABILIFY MAINTENA$124
- ABILIFY ASIMTUFII$124
- QUVIVIQ$124
- Austedo XR$124
- JORNAY PM$121
How this compares
$11,587 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $11,784 |
| Lurasidone Hcl | 30 | $2,390 |
| Atomoxetine Hcl | 11 | $1,283 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $956 |
| Lamotrigine | 99 | $921 |
| Ziprasidone Hcl | 14 | $788 |
| Bupropion XlBupropion Hcl | 35 | $439 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $254 |
| Duloxetine Hcl | 24 | $199 |
| Quetiapine Fumarate | 19 | $195 |
| Clonazepam | 50 | $194 |
| Trazodone Hcl | 25 | $191 |
| Citalopram HbrCitalopram Hydrobromide | 16 | $106 |
| Alprazolam | 12 | $57 |
| Lithium Carbonate ErLithium Carbonate | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Vista
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.